Results 1-4 of 4 for cervical speaker:Jonathan O'Brien

Public Accounts Committee: 2016 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Chapter 23: Accounts of the National Treasury Management Agency
National Treasury Management Agency: Financial Statements 2017 (12 Jul 2018)

Jonathan O'Brien: There is a public perception, whether it is intentional or accidental, that all the misdiagnoses of cervical cancer were as a result of failures by the labs and the screening. We are now told there is a whole cohort of other women, some of whom have taken cases. They were misdiagnoses from non-screening services. Is that an accurate and fair assessment?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Jonathan O'Brien: I understand that when a laboratory has been accredited, Cervical Check conducts quality assurance visits each year. Is that correct?

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Jonathan O'Brien: I might come back to this issue later. There are 11 cases relating to cervical care. Mr. Breen said there were four claims relating to the breast cancer screening programme.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Jonathan O'Brien: Can Mr. Breen say if the four screening services have similar results to those of cervical checks, in terms of false negatives or misdiagnosis etc?